TY - JOUR AU - Klareskog, L. AU - Catrina, A. I. AU - Paget, S. PY - 2009 DA - 2009// TI - Rheumatoid arthritis JO - Lancet. VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60008-8 DO - 10.1016/S0140-6736(09)60008-8 ID - Klareskog2009 ER - TY - JOUR AU - Scott, D. L. AU - Wolfe, F. AU - Huizinga, T. W. PY - 2010 DA - 2010// TI - Rheumatoid arthritis JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60826-4 DO - 10.1016/S0140-6736(10)60826-4 ID - Scott2010 ER - TY - JOUR AU - Leipe, J. AU - Grunke, M. AU - Dechant, C. AU - Reindl, C. AU - Kerzendorf, U. AU - Schulze-Koops, H. PY - 2010 DA - 2010// TI - Role of Th17 cells in human autoimmune arthritis JO - Arthritis Rheum. VL - 62 UR - https://doi.org/10.1002/art.27622 DO - 10.1002/art.27622 ID - Leipe2010 ER - TY - JOUR AU - Goronzy, J. J. AU - Weyand, C. M. PY - 2004 DA - 2004// TI - T-cell regulation in rheumatoid arthritis JO - Curr Opin Rheumatol. VL - 16 UR - https://doi.org/10.1097/00002281-200405000-00008 DO - 10.1097/00002281-200405000-00008 ID - Goronzy2004 ER - TY - JOUR AU - Lundy, S. K. AU - Sarkar, S. AU - Tesmer, L. A. AU - Fox, D. A. PY - 2007 DA - 2007// TI - Cells of the synovium in rheumatoid arthritis: T lymphocytes JO - Arthritis Res Ther. VL - 9 UR - https://doi.org/10.1186/ar2107 DO - 10.1186/ar2107 ID - Lundy2007 ER - TY - JOUR AU - Burmester, G. R. AU - Feist, E. AU - Dörner, T. PY - 2014 DA - 2014// TI - Emerging cell and cytokine targets in rheumatoid arthritis JO - Nat Rev Rheumatol. VL - 10 UR - https://doi.org/10.1038/nrrheum.2013.168 DO - 10.1038/nrrheum.2013.168 ID - Burmester2014 ER - TY - JOUR AU - Komatsu, N. AU - Takayanagi, H. PY - 2012 DA - 2012// TI - Autoimmune arthritis: the interface between the immune system and joints JO - Adv Immunol. VL - 115 UR - https://doi.org/10.1016/B978-0-12-394299-9.00002-3 DO - 10.1016/B978-0-12-394299-9.00002-3 ID - Komatsu2012 ER - TY - JOUR AU - McInnes, I. B. AU - Schett, G. PY - 2007 DA - 2007// TI - Cytokines in the pathogenesis of rheumatoid arthritis JO - Nat Rev Immunol. VL - 7 UR - https://doi.org/10.1038/nri2094 DO - 10.1038/nri2094 ID - McInnes2007 ER - TY - JOUR AU - McInnes, I. B. AU - Schett, G. PY - 2011 DA - 2011// TI - The pathogenesis of rheumatoid arthritis JO - N Engl J Med. VL - 365 UR - https://doi.org/10.1056/NEJMra1004965 DO - 10.1056/NEJMra1004965 ID - McInnes2011 ER - TY - JOUR AU - Francisco, L. M. AU - Sage, P. T. AU - Sharpe, A. H. PY - 2010 DA - 2010// TI - The PD-1 pathway in tolerance and autoimmunity JO - Immunol Rev. VL - 236 UR - https://doi.org/10.1111/j.1600-065X.2010.00923.x DO - 10.1111/j.1600-065X.2010.00923.x ID - Francisco2010 ER - TY - JOUR AU - Fife, B. T. AU - Pauken, K. E. PY - 2011 DA - 2011// TI - The role of the PD-1 pathway in autoimmunity and peripheral tolerance JO - Ann N Y Acad Sci. VL - 1217 UR - https://doi.org/10.1111/j.1749-6632.2010.05919.x DO - 10.1111/j.1749-6632.2010.05919.x ID - Fife2011 ER - TY - JOUR AU - Keir, M. E. AU - Butte, M. J. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2008 DA - 2008// TI - PD-1 and its ligands in tolerance and immunity JO - Annu Rev Immunol. VL - 26 UR - https://doi.org/10.1146/annurev.immunol.26.021607.090331 DO - 10.1146/annurev.immunol.26.021607.090331 ID - Keir2008 ER - TY - JOUR AU - Riella, L. V. AU - Paterson, A. M. AU - Sharpe, A. H. AU - Chandraker, A. PY - 2012 DA - 2012// TI - Role of the PD-1 pathway in the immune response JO - Am J Transplant. VL - 12 UR - https://doi.org/10.1111/j.1600-6143.2012.04224.x DO - 10.1111/j.1600-6143.2012.04224.x ID - Riella2012 ER - TY - JOUR AU - Nishimura, H. AU - Nose, M. AU - Hiai, H. AU - Minato, N. AU - Honjo, T. PY - 1999 DA - 1999// TI - Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor JO - Immunity. VL - 11 UR - https://doi.org/10.1016/S1074-7613(00)80089-8 DO - 10.1016/S1074-7613(00)80089-8 ID - Nishimura1999 ER - TY - JOUR AU - Nishimura, H. AU - Okazaki, T. AU - Tanaka, Y. AU - Nakatani, K. AU - Hara, M. AU - Matsumori, A. PY - 2001 DA - 2001// TI - Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice JO - Science. VL - 291 UR - https://doi.org/10.1126/science.291.5502.319 DO - 10.1126/science.291.5502.319 ID - Nishimura2001 ER - TY - JOUR AU - Wang, J. AU - Yoshida, T. AU - Nakaki, F. AU - Hiai, H. AU - Okazaki, T. AU - Honjo, T. PY - 2005 DA - 2005// TI - Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes JO - Proc Natl Acad Sci U S A. VL - 102 UR - https://doi.org/10.1073/pnas.0505497102 DO - 10.1073/pnas.0505497102 ID - Wang2005 ER - TY - JOUR AU - Suarez-Gestal, M. AU - Ferreiros-Vidal, I. AU - Ortiz, J. A. AU - Gomez-Reino, J. J. AU - Gonzalez, A. PY - 2008 DA - 2008// TI - Analysis of the functional relevance of a putative regulatory SNP of PDCD1, PD-1.3, associated with systemic lupus erythematosus JO - Genes Immun VL - 9 UR - https://doi.org/10.1038/gene.2008.19 DO - 10.1038/gene.2008.19 ID - Suarez-Gestal2008 ER - TY - JOUR AU - Newby, P. R. AU - Roberts-Davies, E. L. AU - Brand, O. J. AU - Heward, J. M. AU - Franklyn, J. A. AU - Gough, S. C. PY - 2007 DA - 2007// TI - Tag SNP screening of the PDCD1 gene for association with Graves’ disease JO - Clin Endocrinol. VL - 67 UR - https://doi.org/10.1111/j.1365-2265.2007.02848.x DO - 10.1111/j.1365-2265.2007.02848.x ID - Newby2007 ER - TY - JOUR AU - Kong, E. K. AU - Prokunina-Olsson, L. AU - Wong, W. H. AU - Lau, C. S. AU - Chan, T. M. AU - Alarcon-Riquelme, M. PY - 2005 DA - 2005// TI - A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese JO - Arthritis Rheum. VL - 52 UR - https://doi.org/10.1002/art.20966 DO - 10.1002/art.20966 ID - Kong2005 ER - TY - JOUR AU - Bertsias, G. K. AU - Nakou, M. AU - Choulaki, C. AU - Raptopoulou, A. AU - Papadimitraki, E. AU - Goulielmos, G. PY - 2009 DA - 2009// TI - Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus JO - Arthritis Rheum. VL - 60 UR - https://doi.org/10.1002/art.24227 DO - 10.1002/art.24227 ID - Bertsias2009 ER - TY - JOUR AU - Gianchecchi, E. AU - Delfino, D. V. AU - Fierabracci, A. PY - 2013 DA - 2013// TI - Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity JO - Autoimmun Rev. VL - 12 UR - https://doi.org/10.1016/j.autrev.2013.05.003 DO - 10.1016/j.autrev.2013.05.003 ID - Gianchecchi2013 ER - TY - JOUR AU - Hatachi, S. AU - Iwai, Y. AU - Kawano, S. AU - Morinobu, S. AU - Kobayashi, M. AU - Koshiba, M. PY - 2003 DA - 2003// TI - CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid JO - J Rheumatol. VL - 30 ID - Hatachi2003 ER - TY - JOUR AU - Raptopoulou, A. P. AU - Bertsias, G. AU - Makrygiannakis, D. AU - Verginis, P. AU - Kritikos, I. AU - Tzardi, M. PY - 2010 DA - 2010// TI - The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis JO - Arthritis Rheum. VL - 62 ID - Raptopoulou2010 ER - TY - JOUR AU - Moret, F. M. AU - Wurff-Jacobs, K. M. AU - Bijlsma, J. W. AU - Lafeber, F. P. AU - Roon, J. A. PY - 2014 DA - 2014// TI - Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions JO - Arthritis Res Ther. VL - 16 UR - https://doi.org/10.1186/s13075-014-0497-x DO - 10.1186/s13075-014-0497-x ID - Moret2014 ER - TY - JOUR AU - Nielsen, C. AU - Ohm-Laursen, L. AU - Barington, T. AU - Husby, S. AU - Lillevang, S. T. PY - 2005 DA - 2005// TI - Alternative splice variants of the human PD-1 gene JO - Cell Immunol. VL - 235 UR - https://doi.org/10.1016/j.cellimm.2005.07.007 DO - 10.1016/j.cellimm.2005.07.007 ID - Nielsen2005 ER - TY - JOUR AU - Shin, S. P. AU - Seo, H. H. AU - Shin, J. H. AU - Park, H. B. AU - Lim, D. P. AU - Eom, H. S. PY - 2013 DA - 2013// TI - Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response JO - Mol Ther. VL - 21 UR - https://doi.org/10.1038/mt.2012.252 DO - 10.1038/mt.2012.252 ID - Shin2013 ER - TY - JOUR AU - Amancha, P. K. AU - Hong, J. J. AU - Rogers, K. AU - Ansari, A. A. AU - Villinger, F. PY - 2013 DA - 2013// TI - In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit JO - J Immunol. VL - 191 UR - https://doi.org/10.4049/jimmunol.1302044 DO - 10.4049/jimmunol.1302044 ID - Amancha2013 ER - TY - JOUR AU - He, Y. F. AU - Zhang, G. M. AU - Wang, X. H. AU - Zhang, H. AU - Yuan, Y. AU - Li, D. PY - 2004 DA - 2004// TI - Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine JO - J Immunol. VL - 173 UR - https://doi.org/10.4049/jimmunol.173.8.4919 DO - 10.4049/jimmunol.173.8.4919 ID - He2004 ER - TY - JOUR AU - Onlamoon, N. AU - Rogers, K. AU - Mayne, A. E. AU - Pattanapanyasat, K. AU - Mori, K. AU - Mori, K. PY - 2008 DA - 2008// TI - Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection JO - Immunology. VL - 124 UR - https://doi.org/10.1111/j.1365-2567.2007.02766.x DO - 10.1111/j.1365-2567.2007.02766.x ID - Onlamoon2008 ER - TY - JOUR AU - Dai, S. AU - Jia, R. AU - Zhang, X. AU - Fang, Q. AU - Huang, L. PY - 2014 DA - 2014// TI - The PD-1/PD-Ls pathway and autoimmune diseases JO - Cell Immunol. VL - 290 UR - https://doi.org/10.1016/j.cellimm.2014.05.006 DO - 10.1016/j.cellimm.2014.05.006 ID - Dai2014 ER - TY - JOUR AU - Wu, H. AU - Miao, M. AU - Zhang, G. AU - Hu, Y. AU - Ming, Z. AU - Zhang, X. PY - 2009 DA - 2009// TI - Soluble PD-1 is associated with aberrant regulation of T cells activation in aplastic anemia JO - Immunol Invest. VL - 38 UR - https://doi.org/10.1080/08820130902912332 DO - 10.1080/08820130902912332 ID - Wu2009 ER - TY - JOUR AU - Wan, B. AU - Nie, H. AU - Liu, A. AU - Feng, G. AU - He, D. AU - Xu, R. PY - 2006 DA - 2006// TI - Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis JO - J Immunol. VL - 177 UR - https://doi.org/10.4049/jimmunol.177.12.8844 DO - 10.4049/jimmunol.177.12.8844 ID - Wan2006 ER - TY - JOUR AU - Greisen, S. R. AU - Rasmussen, T. K. AU - Stengaard-Pedersen, K. AU - Hetland, M. L. AU - Hørslev-Petersen, K. AU - Hvid, M. PY - 2014 DA - 2014// TI - Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis JO - Scand J Rheumatol. VL - 43 UR - https://doi.org/10.3109/03009742.2013.823517 DO - 10.3109/03009742.2013.823517 ID - Greisen2014 ER - TY - JOUR AU - Chen, Y. AU - Hu, Z. AU - Wang, Q. AU - Ge, Y. AU - Bai, L. AU - Wang, X. PY - 2010 DA - 2010// TI - Generation and characterization of four novel monoclonal antibodies against human programmed death-1 molecule JO - Hybridoma (Larchmt) VL - 29 UR - https://doi.org/10.1089/hyb.2009.0091 DO - 10.1089/hyb.2009.0091 ID - Chen2010 ER - TY - JOUR AU - Dulos, J. AU - Carven, G. J. AU - Boxtel, S. J. AU - Evers, S. AU - Driessen-Engels, L. J. AU - Hobo, W. PY - 2012 DA - 2012// TI - PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer JO - J Immunother. VL - 35 UR - https://doi.org/10.1097/CJI.0b013e318247a4e7 DO - 10.1097/CJI.0b013e318247a4e7 ID - Dulos2012 ER -